You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study
|
|---|---|
| Published in |
Journal of Clinical Oncology, September 2020
|
| DOI | 10.1200/jco.20.00948 |
| Pubmed ID | |
| Authors |
Arnon P. Kater, Jenny Qun Wu, Thomas Kipps, Barbara Eichhorst, Peter Hillmen, James D’Rozario, Sarit Assouline, Carolyn Owen, Tadeusz Robak, Javier de la Serna, Ulrich Jaeger, Guillaume Cartron, Marco Montillo, Julie Dubois, Eric Eldering, Clemens Mellink, Anne-Marie Van Der Kevie-Kersemaekers, Su Young Kim, Brenda Chyla, Elizabeth Punnoose, Christopher R. Bolen, Zoe June Assaf, Yanwen Jiang, Jue Wang, Marcus Lefebure, Michelle Boyer, Kathryn Humphrey, John F. Seymour |
X Demographics
The data shown below were collected from the profiles of 46 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 10 | 22% |
| United States | 6 | 13% |
| Italy | 2 | 4% |
| India | 2 | 4% |
| Saudi Arabia | 1 | 2% |
| Mexico | 1 | 2% |
| Canada | 1 | 2% |
| United Kingdom | 1 | 2% |
| Brazil | 1 | 2% |
| Other | 2 | 4% |
| Unknown | 19 | 41% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 30 | 65% |
| Practitioners (doctors, other healthcare professionals) | 10 | 22% |
| Scientists | 5 | 11% |
| Science communicators (journalists, bloggers, editors) | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 148 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 148 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 21 | 14% |
| Researcher | 19 | 13% |
| Student > Ph. D. Student | 16 | 11% |
| Student > Bachelor | 11 | 7% |
| Student > Doctoral Student | 6 | 4% |
| Other | 21 | 14% |
| Unknown | 54 | 36% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 39 | 26% |
| Biochemistry, Genetics and Molecular Biology | 21 | 14% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 5% |
| Agricultural and Biological Sciences | 4 | 3% |
| Immunology and Microbiology | 3 | 2% |
| Other | 16 | 11% |
| Unknown | 58 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 59. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 April 2023.
All research outputs
#734,544
of 25,698,912 outputs
Outputs from Journal of Clinical Oncology
#1,696
of 22,229 outputs
Outputs of similar age
#20,921
of 434,850 outputs
Outputs of similar age from Journal of Clinical Oncology
#29
of 153 outputs
Altmetric has tracked 25,698,912 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,229 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.1. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 434,850 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 153 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.